Where is Feminax Ultra used?
Feminax Ultra is a tablet form medication that contains 250 mg of Naproxen as an active ingredient. This is used for the treatment of primary dysmenorrhea and is recommended as one of the primary treatments for gout attacks. This medication is licensed for use in women aged 15 to 50 years for primary dysmenorrhea. Primary dysmenorrhea is associated with cramps and pains before or during menstruation.
Why is Feminax Ultra used for primary dysmenorrhea and gout attack?
Naproxen, the active ingredient of Feminax Ultra, belongs to a group of medications known as Nonsteroidal anti-inflammatory drugs (NSAIDs). This class of medications decreases inflammation and pain. One of the reasons contributing to symptoms of primary dysmenorrhoea is the increased production of prostaglandins in the body. NSAIDs help stop the production of prostaglandins, which is a primary mechanism of action of this class of the group.
Likewise, prostaglandins are made throughout the gout attack and contribute to the presenting symptoms, hence the basis behind the NSAID treatment.
How to take Feminax Ultra?
The recommended doses for primary dysmenorrhea are:
For the management of gout attack:
This medication is recognized as one of the first medications in the management of gout attacks. Providing there are no contraindications, the following recommended dosage is used in a gout attack:
Feminax Ultra for Gout and Alternative Option
In theory, Feminax Ultra can be used for the management of gout. On the other hand, this medicine is not licensed for this indication. Every pharmacy operates agreeing to set standard operating measures. Patients who demand a medication from a pharmacy are typically asked a set of questions to weigh the need for the product. Common questions which are asked may include:
The sale of Feminax Ultra for gout would be declined depending on the product license.
A patient who is experiencing a gout attack needs to see their doctor get a suitable diagnosis and evaluation. Patients who are recommended NSAIDs for management of acute gout might also be given an H2-antagonist such as Ranitidine or Proton Pump Inhibitors (PPIs) such as Omeprazole or another PPI. These medications defend the stomach from the irritation caused by NSAIDs. The requirement to use protection while on Feminax Ultra or other NSAIDs applies only to particular patient groups. In addition, patient with re-current gout needs a review from the doctor, so that urate-lowering treatment may be measured as preventative rehabilitation.